iRhythm Technologies, Inc. (IRTC)

NASDAQ: IRTC · Real-Time Price · USD
171.06
+1.08 (0.64%)
At close: Sep 2, 2025, 4:00 PM
171.08
+0.02 (0.01%)
After-hours: Sep 2, 2025, 4:39 PM EDT
0.64%
Market Cap5.50B
Revenue (ttm)657.23M
Net Income (ttm)-92.43M
Shares Out 32.13M
EPS (ttm)-2.93
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume346,553
Open170.07
Previous Close169.98
Day's Range169.74 - 171.15
52-Week Range55.92 - 172.59
Beta1.41
AnalystsStrong Buy
Price Target163.82 (-4.23%)
Earnings DateOct 29, 2025

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor t... [Read more]

Sector Healthcare
IPO Date Oct 20, 2016
Employees 2,000
Stock Exchange NASDAQ
Ticker Symbol IRTC
Full Company Profile

Financial Performance

In 2024, iRhythm Technologies's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Financial Statements

Analyst Summary

According to 11 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price target is $163.82, which is a decrease of -4.23% from the latest price.

Price Target
$163.82
(-4.23% downside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from the Oxford University-led A ctive M onitoring for A tria L FI brillation (AMALFI) rando...

4 days ago - GlobeNewsWire

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

13 days ago - GlobeNewsWire

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies

Spruce Point Capital Management issued a detailed report on iRhythm Technologies, Inc. IRTC on Monday, projecting a long-term downside risk of 40% to 70% for its stock.

15 days ago - Benzinga

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ:IRTC) announced the publication of the real-world evidence study: Assessment of Variation in AmbuLatory Cardiac MON...

15 days ago - GlobeNewsWire

iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Daniel G. Wilson - CFO & Principal Financial Officer Quentin S.

4 weeks ago - Seeking Alpha

iRhythm Technologies Announces Second Quarter 2025 Financial Results

SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...

4 weeks ago - GlobeNewsWire

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its...

5 weeks ago - Business Wire

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

6 weeks ago - GlobeNewsWire

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

NEW YORK and NEW ORLEANS , July 11, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.

7 weeks ago - PRNewsWire

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...

2 months ago - GlobeNewsWire

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

2 months ago - GlobeNewsWire

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

2 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

2 months ago - Accesswire

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

2 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

3 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

3 months ago - Accesswire

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

3 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

3 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

3 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

3 months ago - Accesswire

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

iRhythm Technologies Inc IRTC on Thursday reported first quarter 2025 revenue of $158.7 million, up 20.3% year over year, beating the consensus of $153.38 million.

4 months ago - Benzinga

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wi...

4 months ago - Seeking Alpha

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Zio ® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio ® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitor...

4 months ago - GlobeNewsWire

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...

4 months ago - GlobeNewsWire

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed Z...

4 months ago - GlobeNewsWire